Breaking News Instant updates and real-time market news.

ELGX

Endologix

$4.73

0.03 (0.64%)

16:02
08/09/18
08/09
16:02
08/09/18
16:02

Endologix reports Q2 EPS (28c), consensus (15c)

Reports Q2 revenue $44.7M, consensus $44.45M.

  • 09

    Aug

  • 06

    Nov

ELGX Endologix
$4.73

0.03 (0.64%)

10/09/17
ADAM
10/09/17
NO CHANGE
Target $5
ADAM
Hold
Endologix investors should take profits, says Canaccord
Canaccord analyst Jason Mills believes the run in Endologix shares following the FDA approval of the NELLIX confirmatory study is "egregiously overdone" and as a result investors should take profits. Mills, who remains cautious about the company's ability to gain market share in a highly competitive and mature market, maintained his Hold rating and $5.00 price target on Endologix shares.
12/12/17
PIPR
12/12/17
INITIATION
Target $7
PIPR
Overweight
Endologix assumed with an Overweight at Piper Jaffray
Piper Jaffray analyst Matt O'Brian assumed coverage of Endologix with an Overweight rating and $7 price target. The analyst views the company as a "solid player" in the abdominal aortic aneurysms space despite some setbacks.
01/02/18
JPMS
01/02/18
DOWNGRADE
Target $5
JPMS
Underweight
Endologix downgraded to Underweight from Neutral at JPMorgan
JPMorgan analyst Michael Weinstein downgraded Endologix to Underweight and cut his price target for the shares to $5 from $6. The outlook for the company continued to "deteriorate" over the course of 2017 as pipeline and regulatory challenges mounted, Weinstein tells investors in a research note. He sees an "uncertain path to profitability" and a "very long" road to recovery for Endologix.
03/20/18
PIPR
03/20/18
NO CHANGE
PIPR
Endologix ENCORE study a positive sign, says Piper Jaffray
Piper Jaffray analyst Matt O'Brien was positive on Endologix's ENCORE study results for its Ovation product, and continues to believe "additional data reads and imminent approvals in the coming years should lift shares higher." O'Brien maintained an Overweight rating on shares, recommending investors with more risk tolerance or a longer time horizon accumulate shares at this point.

TODAY'S FREE FLY STORIES

HSC

Harsco

$21.94

0.11 (0.50%)

07:19
02/21/19
02/21
07:19
02/21/19
07:19
Earnings
Breaking Earnings news story on Harsco »

Harsco sees Q1 adj. EPS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

CURLF

Curaleaf Holdings

$0.00

(0.00%)

07:19
02/21/19
02/21
07:19
02/21/19
07:19
Initiation
Curaleaf Holdings initiated  »

Curaleaf Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LEN

Lennar

$48.96

-0.42 (-0.85%)

07:18
02/21/19
02/21
07:18
02/21/19
07:18
Downgrade
Lennar rating change  »

Lennar downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HSC

Harsco

$21.94

0.11 (0.50%)

07:18
02/21/19
02/21
07:18
02/21/19
07:18
Earnings
Breaking Earnings news story on Harsco »

Harsco sees FY19 adj. EPS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

CAJ

Canon

$29.12

0.02 (0.07%)

07:18
02/21/19
02/21
07:18
02/21/19
07:18
Upgrade
Canon rating change  »

Canon upgraded to Neutral…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VALE

Vale

$12.24

0.06 (0.49%)

, BHP

BHP Group

$54.16

0.96 (1.80%)

07:17
02/21/19
02/21
07:17
02/21/19
07:17
Periodicals
Brazil's fatal dam collapse may lead to mining industry change, Bloomberg says »

The mining dam collapse…

VALE

Vale

$12.24

0.06 (0.49%)

BHP

BHP Group

$54.16

0.96 (1.80%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NEM

Newmont Mining

$35.37

0.83 (2.40%)

07:17
02/21/19
02/21
07:17
02/21/19
07:17
Hot Stocks
Newmont Mining reports gold reserves of 65.4M attributable ounces for 2018 »

Newmont Mining reported…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

MIC

Macquarie Infrastructure

$43.17

-0.2 (-0.46%)

07:17
02/21/19
02/21
07:17
02/21/19
07:17
Downgrade
Macquarie Infrastructure rating change  »

Macquarie Infrastructure…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

HSC

Harsco

$21.94

0.11 (0.50%)

07:16
02/21/19
02/21
07:16
02/21/19
07:16
Earnings
Harsco reports Q4 ex-items EPS 33c, consensus 28c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

ACB

Aurora Cannabis

$7.06

0.15 (2.17%)

07:16
02/21/19
02/21
07:16
02/21/19
07:16
Initiation
Aurora Cannabis initiated  »

Aurora Cannabis initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WIX

Wix.com

$111.18

-14.52 (-11.55%)

07:16
02/21/19
02/21
07:16
02/21/19
07:16
Recommendations
Wix.com analyst commentary  »

Wix.com price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 25

    Feb

  • 12

    Mar

  • 18

    Mar

ROKU

Roku

$53.63

0.45 (0.85%)

07:16
02/21/19
02/21
07:16
02/21/19
07:16
Recommendations
Roku analyst commentary  »

Large numbers of Roku…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

SAM

Boston Beer

07:16
02/21/19
02/21
07:16
02/21/19
07:16
Upgrade
Boston Beer rating change  »

Boston Beer upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

X

U.S. Steel

$24.00

0.96 (4.17%)

07:15
02/21/19
02/21
07:15
02/21/19
07:15
Upgrade
U.S. Steel rating change  »

U.S. Steel upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CGC

Canopy Growth

$46.18

-0.2 (-0.43%)

, STZ

Constellation Brands

$166.78

-7.9803 (-4.57%)

07:15
02/21/19
02/21
07:15
02/21/19
07:15
Initiation
Canopy Growth, Constellation Brands, Constellation Brands; also tag STZ initiated  »

Canopy Growth initiated…

CGC

Canopy Growth

$46.18

-0.2 (-0.43%)

STZ

Constellation Brands

$166.78

-7.9803 (-4.57%)

STZ.B

Constellation Brands; also tag STZ

$174.10

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBLK

Carbon Black

$16.47

0.13 (0.80%)

07:15
02/21/19
02/21
07:15
02/21/19
07:15
Recommendations
Carbon Black analyst commentary  »

Carbon Black price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 04

    Mar

  • 05

    Mar

  • 13

    Mar

ANIX

Anixa Biosciences

$5.55

0.22 (4.13%)

07:15
02/21/19
02/21
07:15
02/21/19
07:15
Hot Stocks
Anixa Biosciences extends collaboration with The Wistar Institute »

Anixa Biosciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

07:15
02/21/19
02/21
07:15
02/21/19
07:15
General news
FX Update: The dollar lifted on ascending hopes for a U.S.-China trade deal »

FX Update: The dollar…

FOCS

Focus Financial Partners

$30.59

0.27 (0.89%)

07:14
02/21/19
02/21
07:14
02/21/19
07:14
Earnings
Focus Financial Partners reports Q4 adj. EPS 51c, consensus 50c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 12

    Mar

GPI

Group 1 Automotive

$63.62

2.05 (3.33%)

07:14
02/21/19
02/21
07:14
02/21/19
07:14
Hot Stocks
Group 1 Automotive raises share repurchase authorization to $75M »

Group 1 Automotive…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Mar

  • 06

    Mar

OGE

OGE Energy

$41.94

0.01 (0.02%)

07:13
02/21/19
02/21
07:13
02/21/19
07:13
Earnings
Breaking Earnings news story on OGE Energy »

OGE Energy sees FY19 EPS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

AERI

Aerie Pharmaceuticals

$39.56

-1.25 (-3.06%)

07:13
02/21/19
02/21
07:13
02/21/19
07:13
Recommendations
Aerie Pharmaceuticals analyst commentary  »

Aerie Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 14

    Mar

  • 18

    Mar

OGE

OGE Energy

$41.94

0.01 (0.02%)

07:12
02/21/19
02/21
07:12
02/21/19
07:12
Earnings
OGE Energy reports Q4 EPS 27c, consensus 23c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

BRC

Brady

$47.35

0.59 (1.26%)

07:12
02/21/19
02/21
07:12
02/21/19
07:12
Earnings
Brady raises FY19 EPS view to $2.25-$2.35 from $2.20-$2.30, consensus $2.28 »

Backs FY19 organic sales…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 28

    Mar

VRCA

Verrica Pharmaceuticals

$10.99

-0.12 (-1.08%)

07:11
02/21/19
02/21
07:11
02/21/19
07:11
Initiation
Verrica Pharmaceuticals initiated  »

Verrica Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.